未播出

持續追蹤 · 1 篇報導

FDA panel review of seven unapproved peptides

首次播出 最新播出

發展中下次查核 ：The committee’s recommendations on whether pharmacies may compound and dispense the seven peptides.

最新進展

The FDA Pharmacy Compounding Advisory Committee began its two-day review of seven unapproved peptides on July 23. FDA career scientists recommended against compounding all seven, citing a lack of human clinical data for three and inadequate data for the others; the committee’s recommendations have not yet been reported.

新聞追蹤第 1 天

1 篇報導11 家媒體11 個來源1 部影片

  • 尚無標註日期的事件
    1. 第 1 次更新Six Against the Scientists: An FDA Panel Backs Peptides With No Clinical Track Record

    事件至今

    1. 第 1 次更新

      Six Against the Scientists: An FDA Panel Backs Peptides With No Clinical Track Record

      A two-day meeting in Washington ended with a narrow recommendation to loosen compounding rules for unapproved compounds championed by influencers and RFK Jr. — over the objections of the agency's own staff.

      本篇報導後仍無定論

      • Whether the FDA will adopt the committee's recommendation in full or in part.
      • Which specific peptides failed to win a majority, given the gap between seven on the agenda and six (or four) endorsed.

    經過

    1. 開啟1 篇報導

    相關各方

    人物

    • Joe RoganAmerican broadcaster, comedian, and actor (born 1967)1 篇報導
    • Robert F. Kennedy Jr.26th United States Secretary of Health and Human Services since 20251 篇報導

    地點

    • ChinaChina1 篇報導
    • WashingtonWashington, DC, USA1 篇報導

    我們就此事閱讀過的所有媒體

    11 個來源11 家媒體1 部影片